Cargando…

Knockdown of T Cell Immunoglobulin and Mucin 1 (Tim-1) Suppresses Glioma Progression Through Inhibition of the Cytokine-PI3K/AKT Pathway

BACKGROUND: Glioma is formed by abnormal proliferation of glial cells in the brain. T cell immunoglobulin and mucin 1 (Tim-1) is linked to cancer development. This study aimed to assess Tim-1 functions in biological behaviors. METHODS: The glioma tissues and paracancerous tissues were collected. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Peng, Fei, Maoxing, Han, Yanling, Zhou, Mengliang, Wang, Handong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414978/ https://www.ncbi.nlm.nih.gov/pubmed/32801766 http://dx.doi.org/10.2147/OTT.S255117

Ejemplares similares

Inhibition of T cell immunoglobulin and mucin-1 (TIM-1) protects against cerebral ischemia-reperfusion injury
por: Zheng, Yueying, et al.
Publicado: (2019)

Correction to: Inhibition of T cell immunoglobulin and mucin-1 (TIM-1) protects against cerebral ischemia-reperfusion injury
por: Zheng, Yueying, et al.
Publicado: (2019)

T-Cell Immunoglobulin and Mucin Domain 1 (TIM-1) Is a Functional Entry Factor for Tick-Borne Encephalitis Virus
por: Zhang, Xiaowei, et al.
Publicado: (2022)

Knockdown of Annexin-A1 Inhibits Growth, Migration and Invasion of Glioma Cells by Suppressing the PI3K/Akt Signaling Pathway
por: Wei, Liqing, et al.
Publicado: (2021)

ARID4B Knockdown Suppresses PI3K/AKT Signaling and Induces Apoptosis in Human Glioma Cells
por: Luo, Siou-Min, et al.
Publicado: (2021)

Structures of T Cell Immunoglobulin Mucin Receptors 1 and 2 Reveal Mechanisms for Regulation of Immune Responses by the TIM Receptor Family
por: Santiago, César, et al.
Publicado: (2007)

Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)
por: Homayouni, Vida, et al.
Publicado: (2016)

T Cell Immunoglobulin and Mucin Domain 3 (TIM-3) in Cutaneous Melanoma: A Narrative Review
por: Cazzato, Gerardo, et al.
Publicado: (2023)

Regulation of Th1 T Cell Differentiation by Iron via Upregulation of T Cell Immunoglobulin and Mucin Containing Protein-3 (TIM-3)
por: Pfeifhofer-Obermair, Christa, et al.
Publicado: (2021)

Altered expression of T cell Immunoglobulin-Mucin (TIM) molecules in bronchoalveolar lavage CD4(+ )T cells in sarcoidosis
por: Idali, Farah, et al.
Publicado: (2009)

T Cell Immunoglobulin Mucin Domain (TIM)-3 Promoter Activity in a Human Mast Cell Line
por: Kim, Jung Sik, et al.
Publicado: (2012)

Altered expression of T cell Immunoglobulin-Mucin (Tim) molecules in peripheral blood mononuclear cells in aplastic anemia
por: Liu, Xin, et al.
Publicado: (2014)

Higher T cell immunoglobulin mucin-3 (Tim-3) expression in cervical cancer is associated with a satisfactory prognosis
por: Wang, Yaping, et al.
Publicado: (2020)

Knockdown of DNA polymerase ζ relieved the chemoresistance of glioma via inhibiting the PI3K/AKT signaling pathway
por: Yang, Junbao, et al.
Publicado: (2021)

Knockdown of Nrf2 radiosensitizes glioma cells by inducing redox stress and apoptosis in hypoxia
por: Tang, Ting, et al.
Publicado: (2022)

Knockdown of STIL suppresses the progression of gastric cancer by down‐regulating the IGF‐1/PI3K/AKT pathway
por: Wang, Ju, et al.
Publicado: (2019)

Knockdown of SPOCK1 Inhibits the Proliferation and Invasion in Colorectal Cancer Cells by Suppressing the PI3K/Akt Pathway
por: Zhao, Ping, et al.
Publicado: (2016)

TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway
por: Chen, Liuyan, et al.
Publicado: (2022)

Association of T-Cell Immunoglobulin and Mucin Domain-Containing Molecule 3 (Tim-3) Polymorphisms with Susceptibility and Disease Progression of HBV Infection
por: Liao, Jingyu, et al.
Publicado: (2014)

Knockdown of NOLC1 Inhibits PI3K-AKT Pathway to Improve the Poor Prognosis of Esophageal Carcinoma
por: Kong, Fanguo, et al.
Publicado: (2021)

Knockdown of MMP-1 inhibits the progression of colorectal cancer by suppressing the PI3K/Akt/c-myc signaling pathway and EMT
por: Wang, Kai, et al.
Publicado: (2020)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022)

LncRNA NEAT1 Enhances Glioma Progression via Regulating the miR-128-3p/ITGA5 Axis
por: Chen, Jiakai, et al.
Publicado: (2021)

Downregulation of FHL1 protein in glioma inhibits tumor growth through PI3K/AKT signaling
por: Li, San-Zhong, et al.
Publicado: (2020)

Double-Targeted Knockdown of miR-21 and CXCR4 Inhibits Malignant Glioma Progression by Suppression of the PI3K/AKT and Raf/MEK/ERK Pathways
por: Liu, Feijiao, et al.
Publicado: (2020)

Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway
por: Zhao, Xin, et al.
Publicado: (2019)

Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K/Akt/mTOR pathway
por: Feng, Guofei, et al.
Publicado: (2023)

TIM-4 orchestrates mitochondrial homeostasis to promote lung cancer progression via ANXA2/PI3K/AKT/OPA1 axis
por: Wang, Yuzhen, et al.
Publicado: (2023)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies
por: Phong, Binh, et al.
Publicado: (2016)

Cinnamaldehyde Downregulation of Sept9 Inhibits Glioma Progression through Suppressing Hif-1α via the Pi3k/Akt Signaling Pathway
por: Wang, Zhiwen, et al.
Publicado: (2022)

Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3β/β-catenin pathway
por: Xiang, Zijin, et al.
Publicado: (2020)

EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway
por: Xie, Cheng, et al.
Publicado: (2020)

Knockdown of PDX1 enhances the osteogenic differentiation of ADSCs partly via activation of the PI3K/Akt signaling pathway
por: Liu, Fan, et al.
Publicado: (2022)

The sialidase NEU1 directly interacts with the juxtamembranous segment of the cytoplasmic domain of mucin-1 to inhibit downstream PI3K-Akt signaling
por: Hyun, Sang W., et al.
Publicado: (2021)

MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway
por: Li, Chong, et al.
Publicado: (2020)

Hydroxytyrosol Alleviated Hypoxia-Mediated PC12 Cell Damage through Activating PI3K/AKT/mTOR-HIF-1α Signaling
por: Li, Xiaolin, et al.
Publicado: (2022)

Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm
por: Younan, Patrick, et al.
Publicado: (2017)

CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma
por: Zi, Dan, et al.
Publicado: (2022)

Knockdown of linc01023 restrains glioma proliferation, migration and invasion by regulating IGF-1R/AKT pathway
por: Yu, Mingjun, et al.
Publicado: (2019)

Knockdown of Malic Enzyme 2 Suppresses Lung Tumor Growth, Induces Differentiation and Impacts PI3K/AKT Signaling
por: Ren, Jian-Guo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o21l0ev4mj20jbpfe21l828c10